[
  {
    "ts": null,
    "headline": "The Weight Loss Drug Market Has Gotten Messy. What to Know.",
    "summary": "Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.  Earlier this week,  Novo Nordisk   tore up a partnership with the telehealth storefront  Hims & Hers Health  which had allowed Hims to sell the Novo weight loss drug Wegovy at a lower price for cash-paying patients.",
    "url": "https://finnhub.io/api/news?id=c243eb798d4f9d8bb1c6d5c22d2ea03fa22de8a8887fae27edda78786acf8185",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750801800,
      "headline": "The Weight Loss Drug Market Has Gotten Messy. What to Know.",
      "id": 135511510,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Compounded weight loss drugs have been mostly off the market for about a month, but the weight loss drug industry remains as unsettled as ever.  Earlier this week,  Novo Nordisk   tore up a partnership with the telehealth storefront  Hims & Hers Health  which had allowed Hims to sell the Novo weight loss drug Wegovy at a lower price for cash-paying patients.",
      "url": "https://finnhub.io/api/news?id=c243eb798d4f9d8bb1c6d5c22d2ea03fa22de8a8887fae27edda78786acf8185"
    }
  },
  {
    "ts": null,
    "headline": "Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care",
    "summary": "HIMS expands its weight loss platform with a bundled Wegovy program and tech-driven obesity care solutions.",
    "url": "https://finnhub.io/api/news?id=ac301347d1aa4441ab55b024cca70f11802814b32acb5ca8e96c480cf3bd7e13",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750780140,
      "headline": "Hims & Hers Strengthens Its Footprint in Consumer-Driven Obesity Care",
      "id": 135509828,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "HIMS expands its weight loss platform with a bundled Wegovy program and tech-driven obesity care solutions.",
      "url": "https://finnhub.io/api/news?id=ac301347d1aa4441ab55b024cca70f11802814b32acb5ca8e96c480cf3bd7e13"
    }
  },
  {
    "ts": null,
    "headline": "Can Novo Nordisk Regain Ground After Cutting Ties With Hims & Hers?",
    "summary": "NVO ends its deal with HIMS over safety concerns tied to compounded Wegovy, hitting patient access and market share plans.",
    "url": "https://finnhub.io/api/news?id=ef29cf30cb81d42a141e8e57af02e21726ef6097f5115eb610279407a73f52d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750778700,
      "headline": "Can Novo Nordisk Regain Ground After Cutting Ties With Hims & Hers?",
      "id": 135509829,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "NVO ends its deal with HIMS over safety concerns tied to compounded Wegovy, hitting patient access and market share plans.",
      "url": "https://finnhub.io/api/news?id=ef29cf30cb81d42a141e8e57af02e21726ef6097f5115eb610279407a73f52d2"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?",
    "summary": "PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of resilience.",
    "url": "https://finnhub.io/api/news?id=5c4f7360a1b1e638f10f9ab708d3565e404a83552a33b49e9cbfe943a62a8e22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750775100,
      "headline": "Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?",
      "id": 135506341,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of resilience.",
      "url": "https://finnhub.io/api/news?id=5c4f7360a1b1e638f10f9ab708d3565e404a83552a33b49e9cbfe943a62a8e22"
    }
  },
  {
    "ts": null,
    "headline": "Will CVS Health's Formulary Move Boost Its Weight Management Program?",
    "summary": "CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.",
    "url": "https://finnhub.io/api/news?id=b185bba0da5d116f81c8e579de024d6ef5db31e1b793a673cc2ef522874cd159",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750771200,
      "headline": "Will CVS Health's Formulary Move Boost Its Weight Management Program?",
      "id": 135506286,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.",
      "url": "https://finnhub.io/api/news?id=b185bba0da5d116f81c8e579de024d6ef5db31e1b793a673cc2ef522874cd159"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference",
    "summary": "Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential. Bernstein SocGen Group reaffirmed its Outperform rating and $1,100 price target for Eli Lilly & Company (NYSE:LLY) on June 13 ahead of the 85th Annual Meeting of the American Diabetes Association. The firm outlined a number of crucial data […]",
    "url": "https://finnhub.io/api/news?id=ea1592f5b356d51374b2c86cf2deb6f44011171d7dbc8b29ece0d65d04200b8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750753531,
      "headline": "Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference",
      "id": 135497033,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential. Bernstein SocGen Group reaffirmed its Outperform rating and $1,100 price target for Eli Lilly & Company (NYSE:LLY) on June 13 ahead of the 85th Annual Meeting of the American Diabetes Association. The firm outlined a number of crucial data […]",
      "url": "https://finnhub.io/api/news?id=ea1592f5b356d51374b2c86cf2deb6f44011171d7dbc8b29ece0d65d04200b8d"
    }
  },
  {
    "ts": null,
    "headline": "2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'",
    "summary": "Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are undervalued vs. historical norms.",
    "url": "https://finnhub.io/api/news?id=bcae1d83887a65e6c9f9053eb28696afd7ae4c7b3be1ead657c7a557d5bd0369",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750752000,
      "headline": "2 Dividend Aristocrats Bargains To Buy And 'Never Let Go'",
      "id": 135496728,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1652791120/image_1652791120.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Buying Dividend Aristocrats at bargain prices can be a winning investment strategy. Read about two such stocks that are undervalued vs. historical norms.",
      "url": "https://finnhub.io/api/news?id=bcae1d83887a65e6c9f9053eb28696afd7ae4c7b3be1ead657c7a557d5bd0369"
    }
  },
  {
    "ts": null,
    "headline": "Calamos Phineus Long/Short Fund Q1 2025 Commentary",
    "summary": "Calamos Phineus Long/Short Fund rose 0.93% in Q1 (Class I shares at NAV), compared with a price decline of -4.27% for the S&P 500 Index and loss of -2.15% for the MSCI World Index.",
    "url": "https://finnhub.io/api/news?id=891051a1dc91404d75c34be710173b376dcfbed9ef192ae0a1fbf0322cbe2d8f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750750260,
      "headline": "Calamos Phineus Long/Short Fund Q1 2025 Commentary",
      "id": 135496409,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1787650632/image_1787650632.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Calamos Phineus Long/Short Fund rose 0.93% in Q1 (Class I shares at NAV), compared with a price decline of -4.27% for the S&P 500 Index and loss of -2.15% for the MSCI World Index.",
      "url": "https://finnhub.io/api/news?id=891051a1dc91404d75c34be710173b376dcfbed9ef192ae0a1fbf0322cbe2d8f"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Backs Away From Hims & Hers Partnership",
    "summary": "Novo and Hims’ April team-up turned the two firms from competitors into collaborators at just the right moment.",
    "url": "https://finnhub.io/api/news?id=b04b0c468c09ec1e37d505e7837682684a687cddd5bfaeed23d6e86e72c58f22",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750737660,
      "headline": "Novo Nordisk Backs Away From Hims & Hers Partnership",
      "id": 135497034,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Novo and Hims’ April team-up turned the two firms from competitors into collaborators at just the right moment.",
      "url": "https://finnhub.io/api/news?id=b04b0c468c09ec1e37d505e7837682684a687cddd5bfaeed23d6e86e72c58f22"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: It Is A Bet On Human Longevity",
    "summary": "Eli Lilly: It Is A Bet On Human Longevity",
    "url": "https://finnhub.io/api/news?id=f4734f9ed89681e5c4d7aaac119863830f36683d6f70798b5e625fca2c62fa12",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750723552,
      "headline": "Eli Lilly: It Is A Bet On Human Longevity",
      "id": 135487566,
      "image": "",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f4734f9ed89681e5c4d7aaac119863830f36683d6f70798b5e625fca2c62fa12"
    }
  }
]